Please contact us for more information or to learn if you are eligible to participate.
The primary objective of this study is to test an investigational product, HTD1801 and evaluate the effects on liver fat content (LFC) in adults between 18 and 75 years of age who have been diagnosed with T2DM and nonalcoholic steatohepatitis, also known as NASH.
Rashmee Patil, MD
HighTide Biopharma Pty Ltd
Type of Trial
Randomized, Controlled, Single-Blinded